• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    TCW Special Purpose Acquisition Corp. Appoints Nanxi Liu to Board of Directors

    10/24/22 9:00:00 AM ET
    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto & Home Supply Stores
    Consumer Discretionary
    Get the next $ELAN alert in real time by email

    TCW Special Purpose Acquisition Corp. (NYSE:TSPQ), a $464 million blank check company sponsored by The TCW Group, Inc. ("TCW"), announced that it has appointed Nanxi Liu to the Company's Board of Directors.

    Since April 2021, Ms. Liu has served on the TCW Special Purpose Acquisition Corporation's Advisory Board. She is the Co-Founder and Co-CEO of Blaze Technology, a no-code platform that enables teams to build web applications and internal tools. Ms. Liu co-founded and served as CEO of Enplug, a leading digital signage software company used by Fortune 500 companies, until it was acquired in 2021. She previously co-founded Nanoly Bioscience, a venture-backed biotech company that develops polymers that eliminate the need of refrigeration for vaccines and therapeutics.

    Ms. Liu serves on the Board of Directors of CarParts.com (NASDAQ:PRTS), a leading online provider of automotive parts and accessories, and served on the Board of Directors of Kindred Biosciences (NASDAQ:KIN), a leading biopharmaceutical company for pets, until it was acquired by Elanco Animal Health (NYSE:ELAN). She serves on the Board of Advisors for Covington Capital Management and is a Partner at XFactor Ventures, a leading investor in women-founded startups. Ms. Liu was named one of Forbes 30 Under 30 (in 2016) and Fortune's 10 Most Promising Women Entrepreneurs (in 2015).

    "For the past 18 months, we have benefited from Nanxi's advice and guidance as a member of our Advisory Board, and we are pleased to now welcome her as a new member of the Board of Directors," said Joseph R. Shaposhnik, TCW Special Purpose Acquisition Corp. Chairman and CEO. "She is a highly successful technology entrepreneur and brings a unique perspective to the leaders of businesses and our impressive team of advisors and directors."

    TCW Special Purpose Acquisition Corp. intends to identify, merge with and take public a durable and predictable business well positioned to deliver superior revenue growth. Its management is associated with TCW's New America Premier business unit, which was established by Mr. Shaposhnik in 2015.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities.

    About TCW Special Purpose Acquisition Corp.

    TCW Special Purpose Acquisition Corp. (the "Company"), a Delaware corporation, is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with a private company. The Company is sponsored by The TCW Group, Inc., a leading global investment management firm with approximately $220 billion of assets under management. For more information please visit www.tcwspac.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005377/en/

    Get the next $ELAN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ELAN
    $PRTS
    $TSPQ
    $KIN

    CompanyDatePrice TargetRatingAnalyst
    Elanco Animal Health Incorporated
    $ELAN
    7/17/2025$18.00Market Perform → Outperform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    6/26/2025Mkt Perform → Outperform
    William Blair
    CarParts.com Inc.
    $PRTS
    3/6/2025$3.00Hold → Buy
    Craig Hallum
    Elanco Animal Health Incorporated
    $ELAN
    12/9/2024$18.00Buy
    UBS
    Elanco Animal Health Incorporated
    $ELAN
    12/2/2024$14.00Market Perform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    9/19/2024$17.00 → $15.00Overweight → Equal-Weight
    Morgan Stanley
    Elanco Animal Health Incorporated
    $ELAN
    1/5/2024$13.00 → $20.00Hold → Buy
    Stifel
    Elanco Animal Health Incorporated
    $ELAN
    12/19/2023$17.00Buy
    Jefferies
    More analyst ratings

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Huffaker Michael converted options into 18,750 shares, increasing direct ownership by 7% to 275,148 units (SEC Form 4)

      4 - CarParts.com, Inc. (0001378950) (Issuer)

      7/17/25 4:48:17 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • Chief Technology Officer Subramanian Kals converted options into 18,750 shares and covered exercise/tax liability with 5,382 shares, increasing direct ownership by 7% to 205,869 units (SEC Form 4)

      4 - CarParts.com, Inc. (0001378950) (Issuer)

      7/17/25 4:46:57 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • Chief Financial Officer Lockwood Ryan converted options into 18,750 shares and covered exercise/tax liability with 6,709 shares, increasing direct ownership by 7% to 196,141 units (SEC Form 4)

      4 - CarParts.com, Inc. (0001378950) (Issuer)

      7/17/25 4:45:26 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

      The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the worldLaunch to begin immediately with product in market before the end of Q3 2025GREENFIELD, Ind., July 24, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) announced today that Zenrelia™ (ilunocitinib) has received approval by the European Commission. This approval by the EU reinforces Zenrelia's status as a highly effective, convenient, and safe once-daily oral JAK inhibitor. Zenrelia's approval represents a signific

      7/24/25 5:42:00 PM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CarParts.com Sets Second Quarter 2025 Conference Call for Tuesday, August 12, 2025

      TORRANCE, Calif., July 22, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS) will hold a conference call on Tuesday, August 12, 2025 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its financial results for the second quarter ended June 28, 2025. The results will be reported in a press release prior to the call. CarParts.com, Inc. CEO David Meniane and CFO Ryan Lockwood will host the conference call live via an audio webcast. The live webcast of the event can be accessed at www.carparts.com/investor/news-events. A replay of the webcast will be archived on the

      7/22/25 4:01:00 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

      GREENFIELD, Ind., July 10, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its second quarter 2025 financial results on Thursday, August 7, 2025. Elanco will also conduct a conference call on that day with the investment community and media to provide further details about the company's performance. The conference call will begin at 8:00 a.m. Eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link posted on Elanco's website at https://investor.elanco.com/events-and-presentations/d

      7/10/25 8:00:00 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    SEC Filings

    See more
    • Elanco Animal Health Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Elanco Animal Health Inc (0001739104) (Filer)

      6/26/25 4:01:32 PM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CarParts.com Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - CarParts.com, Inc. (0001378950) (Filer)

      6/13/25 4:09:22 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • SEC Form SD filed by Elanco Animal Health Incorporated

      SD - Elanco Animal Health Inc (0001739104) (Filer)

      5/30/25 10:00:37 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kurzius Lawrence Erik bought $211,000 worth of shares (20,000 units at $10.55), increasing direct ownership by 22% to 111,459 units (SEC Form 4)

      4 - Elanco Animal Health Inc (0001739104) (Issuer)

      3/11/25 5:13:30 PM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Hoover R David bought $272,558 worth of shares (25,000 units at $10.90) (SEC Form 4)

      4 - Elanco Animal Health Inc (0001739104) (Issuer)

      3/7/25 4:21:21 PM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Harrington Michael J bought $51,974 worth of shares (3,500 units at $14.85), increasing direct ownership by 5% to 81,094 units (SEC Form 4)

      4 - Elanco Animal Health Inc (0001739104) (Issuer)

      8/26/24 5:05:35 PM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Elanco Animal Health upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Elanco Animal Health from Market Perform to Outperform and set a new price target of $18.00

      7/17/25 7:51:30 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Elanco Animal Health upgraded by William Blair

      William Blair upgraded Elanco Animal Health from Mkt Perform to Outperform

      6/26/25 7:49:03 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CarParts.com upgraded by Craig Hallum with a new price target

      Craig Hallum upgraded CarParts.com from Hold to Buy and set a new price target of $3.00

      3/6/25 8:20:37 AM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Leadership Updates

    Live Leadership Updates

    See more
    • Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

      The first-of-its-kind report includes results from multiple surveys revealing just how badly dogs around the country are itching for relief.Data reveals that nearly 9 in 10 dogs in the U.S. are "itchy dogs" according to their pet owners, having experienced symptoms of itchiness at some point in the year.1Allergy season makes itch worse, with 83% of pet owners saying that increased pollen levels affect their dog's itch.1Veterinarians are the most trusted ally in solving dogs' itch, and the majority of veterinarians say that itchiness is the most frustrating issue they deal with.1Leading veterinarians and canine dermatologists, including Drs. Joya Griffin, Andrew Rosenberg, and Tom Lewis, are

      6/5/25 7:45:00 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

      GREENFIELD, Ind., May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025. VanHimbergen's appointment follows an extensive and competitive search as part of the company's commitment to long-term, sustained value creation. VanHimbergen succeeds Todd Young, who will remain with the company as an advisor through August 31, 2025, to facilitate a smooth transition. VanHimbergen currently serves as the Senior Vice President and Chi

      5/28/25 7:25:00 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Elanco Strengthens Board of Directors with Addition of Stacey Ma

      Ma brings deep manufacturing and innovation expertise GREENFIELD, Ind., Nov. 12, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the appointment of Dr. Stacey Ma to its Board of Directors, effective immediately. Dr. Ma brings extensive global leadership experience in biopharmaceutical development and manufacturing, further strengthening Elanco's expertise in these critical areas. "We are delighted to add Stacey to the Elanco Board," said Lawrence Kurzius, Chairman of the Elanco Board of Directors. "Her deep understanding of product developmen

      11/12/24 8:33:00 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Financials

    Live finance-specific insights

    See more
    • CarParts.com Sets Second Quarter 2025 Conference Call for Tuesday, August 12, 2025

      TORRANCE, Calif., July 22, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS) will hold a conference call on Tuesday, August 12, 2025 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its financial results for the second quarter ended June 28, 2025. The results will be reported in a press release prior to the call. CarParts.com, Inc. CEO David Meniane and CFO Ryan Lockwood will host the conference call live via an audio webcast. The live webcast of the event can be accessed at www.carparts.com/investor/news-events. A replay of the webcast will be archived on the

      7/22/25 4:01:00 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

      GREENFIELD, Ind., July 10, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its second quarter 2025 financial results on Thursday, August 7, 2025. Elanco will also conduct a conference call on that day with the investment community and media to provide further details about the company's performance. The conference call will begin at 8:00 a.m. Eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link posted on Elanco's website at https://investor.elanco.com/events-and-presentations/d

      7/10/25 8:00:00 AM ET
      $ELAN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CarParts.com Reports First Quarter 2025 Results

      TORRANCE, Calif., May 13, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS), a leading eCommerce provider of automotive parts and accessories, and a premier destination for vehicle repair and maintenance needs, is reporting results for the first quarter ended March 29, 2025.  First Quarter 2025 Summary vs. Year-Ago Quarter Net sales decreased 11% to $147.4 million.Gross profit of $47.3 million vs. $53.9 million, with gross margin of 32.1%.Net loss was ($15.3) million, or ($0.27) per share, compared to a net loss of ($6.5) million, or ($0.11) per share.Adjusted EBITDA of ($

      5/13/25 4:01:00 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary

    $ELAN
    $PRTS
    $TSPQ
    $KIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by CarParts.com Inc.

      SC 13G/A - CarParts.com, Inc. (0001378950) (Subject)

      11/12/24 1:35:28 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by CarParts.com Inc.

      SC 13G/A - CarParts.com, Inc. (0001378950) (Subject)

      11/4/24 10:24:21 AM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by CarParts.com Inc.

      SC 13G/A - CarParts.com, Inc. (0001378950) (Subject)

      9/10/24 12:09:00 PM ET
      $PRTS
      Auto & Home Supply Stores
      Consumer Discretionary